Allergic 0 8 0 8 O
to 9 11 9 11 O
iodinated 12 21 12 21 B-allergy_name
contrast 22 30 22 30 I-allergy_name
if 31 33 31 33 O
undergoing 34 44 34 44 O
a 45 46 45 46 O
contrast 47 55 47 55 O
enhanced 56 64 56 64 O
CT 65 67 65 67 O
scan 68 72 68 72 O
of 73 75 73 75 O
the 76 79 76 79 O
pelvis 80 86 80 86 O

Bilirubin 0 9 87 96 B-clinical_variable
( 10 11 97 98 O
sum 11 14 98 101 O
of 15 17 102 104 O
conjugated 18 28 105 115 O
+ 29 30 116 117 O
unconjugated 31 43 118 130 O
) 43 44 130 131 O
< 45 46 132 133 O
1.5 47 50 134 137 B-upper_bound
mg 51 53 138 140 I-upper_bound
/ 53 54 140 141 I-upper_bound
dl 54 56 141 143 I-upper_bound

Biopsy 0 6 144 150 B-treatment

Concomitant 0 11 151 162 B-treatment
Medications 12 23 163 174 I-treatment
, 23 24 174 175 O
if 25 27 176 178 O
taken 28 33 179 184 O
within 34 40 185 191 O
the 41 44 192 195 O
last 45 49 196 200 B-upper_bound
28 50 52 201 203 I-upper_bound
days 53 57 204 208 I-upper_bound

Evidence 0 8 209 217 O
of 9 11 218 220 O
para 12 16 221 225 B-chronic_disease
- 16 17 225 226 I-chronic_disease
aortic 17 23 226 232 I-chronic_disease
lymphadenopathy 24 39 233 248 I-chronic_disease
or 40 42 249 251 O
distant 43 50 252 259 B-cancer
metastases 51 61 260 270 I-cancer

Examination 0 11 271 282 O
under 12 17 283 288 O
anesthesia 18 28 289 299 B-treatment
( 29 30 300 301 O
if 30 32 301 303 O
indicated 33 42 304 313 O
) 42 43 313 314 O

Growth 0 6 315 321 O
factor(s 7 15 322 330 O
): 15 17 330 332 O
Growth 18 24 333 339 O
factors 25 32 340 347 O
that 33 37 348 352 O
support 38 45 353 360 O
platelet 46 54 361 369 O
or 55 57 370 372 O
white 58 63 373 378 O
cell 64 68 379 383 O
number 69 75 384 390 O
or 76 78 391 393 O
function 79 87 394 402 O
must 88 92 403 407 O
not 93 96 408 411 O
have 97 101 412 416 O
been 102 106 417 421 O
administered 107 119 422 434 O
within 120 126 435 441 O
the 127 130 442 445 O
past 131 135 446 450 B-upper_bound
28 136 138 451 453 I-upper_bound
days 139 143 454 458 I-upper_bound

Hemoglobin 0 10 459 469 B-clinical_variable
≥ 11 12 470 471 O
8.0 13 16 472 475 B-lower_bound
g 17 18 476 477 I-lower_bound
/ 18 19 477 478 I-lower_bound
dL 19 21 478 480 I-lower_bound
( 22 23 481 482 O
Note 23 27 482 486 O
: 27 28 486 487 O
The 29 32 488 491 O
use 33 36 492 495 O
of 37 39 496 498 O
transfusion 40 51 499 510 O
or 52 54 511 513 O
other 55 60 514 519 O
intervention 61 73 520 532 O
to 74 76 533 535 O
achieve 77 84 536 543 O
Hgb 85 88 544 547 B-clinical_variable
≥ 89 90 548 549 O
8.0 91 94 550 553 O
g 95 96 554 555 O
/ 96 97 555 556 O
dL 97 99 556 558 O
is 100 102 559 561 O
acceptable 103 113 562 572 O
) 113 114 572 573 O

Histologically 0 14 574 588 O
- 14 15 588 589 O
proven 15 21 589 595 O
, 21 22 595 596 O
invasive 23 31 597 605 O
primary 32 39 606 613 O
carcinoma 40 49 614 623 B-cancer
of 50 52 624 626 I-cancer
the 53 56 627 630 I-cancer
cervix 57 63 631 637 I-cancer

Intravenous 0 11 638 649 B-treatment
pyelogram 12 21 650 659 I-treatment
and/or 22 28 660 666 O
cystoscopy 29 39 667 677 B-treatment
( 40 41 678 679 O
if 41 43 679 681 O
indicated 44 53 682 691 O
) 53 54 691 692 O

Performance 0 11 693 704 O
Level 12 17 705 710 O
: 17 18 710 711 O
Karnofsky 19 28 712 721 B-clinical_variable
Performance 29 40 722 733 I-clinical_variable
Status 41 47 734 740 I-clinical_variable
≥ 48 49 741 742 O
60 50 52 743 745 B-lower_bound
- 53 54 746 747 O
Peripheral 55 65 748 758 B-clinical_variable
≥ 66 67 759 760 O
ANC 68 71 761 764 B-clinical_variable
1500 72 76 765 769 B-lower_bound
/ 76 77 769 770 I-lower_bound
uL 77 79 770 772 I-lower_bound

Platelet 0 8 773 781 B-clinical_variable
count 9 14 782 787 I-clinical_variable
≥ 15 16 788 789 O
100,000 17 24 790 797 B-lower_bound
/ 24 25 797 798 I-lower_bound
uL 25 27 798 800 I-lower_bound
( 28 29 801 802 O
transfusion 29 40 802 813 O
independent 41 52 814 825 O
) 52 53 825 826 O

Pregnancy 0 9 827 836 B-pregnancy
or 10 12 837 839 O
Breast 13 19 840 846 O
- 19 20 846 847 O
Feeding 20 27 847 854 O
: 27 28 854 855 O
Pregnant 29 37 856 864 B-pregnancy
or 38 40 865 867 O
breast 41 47 868 874 O
- 47 48 874 875 O
feeding 48 55 875 882 O
women 56 61 883 888 B-gender
will 62 66 889 893 O
not 67 70 894 897 O
be 71 73 898 900 O
entered 74 81 901 908 O
on 82 84 909 911 O
this 85 89 912 916 O
study 90 95 917 922 O
due 96 99 923 926 O
to 100 102 927 929 O
risks 103 108 930 935 O
of 109 111 936 938 O
fetal 112 117 939 944 O
and 118 121 945 948 O
teratogenic 122 133 949 960 O
adverse 134 141 961 968 O
events.(Note 142 154 969 981 O
: 154 155 981 982 O
Serum 156 161 983 988 O
Pregnancy 162 171 989 998 O
tests 172 177 999 1004 O
must 178 182 1005 1009 O
be 183 185 1010 1012 O
obtained 186 194 1013 1021 O
in 195 197 1022 1024 O
women 198 203 1025 1030 O
of 204 206 1031 1033 O
child 207 212 1034 1039 O
bearing 213 220 1040 1047 O
potential 221 230 1048 1057 O
) 230 231 1057 1058 O

Prior 0 5 1059 1064 O
invasive 6 14 1065 1073 B-cancer
malignancy 15 25 1074 1084 I-cancer
( 26 27 1085 1086 O
except 27 33 1086 1092 O
non 34 37 1093 1096 B-cancer
- 37 38 1096 1097 I-cancer
melanomatous 38 50 1097 1109 I-cancer
skin 51 55 1110 1114 I-cancer
cancer 56 62 1115 1121 I-cancer
) 62 63 1121 1122 O
, 63 64 1122 1123 O
unless 65 71 1124 1130 O
disease 72 79 1131 1138 O
free 80 84 1139 1143 O
for 85 88 1144 1147 O
a 89 90 1148 1149 O
minimum 91 98 1150 1157 O
of 99 101 1158 1160 O
3 102 103 1161 1162 B-lower_bound
years 104 109 1163 1168 I-lower_bound

Prior 0 5 1169 1174 O
radiotherapy 6 18 1175 1187 B-treatment
to 19 21 1188 1190 O
the 22 25 1191 1194 O
pelvis 26 32 1195 1201 O

Prior 0 5 1202 1207 O
systemic 6 14 1208 1216 B-treatment
chemotherapy 15 27 1217 1229 I-treatment
within 28 34 1230 1236 O
the 35 38 1237 1240 O
last 39 43 1241 1245 O
three 44 49 1246 1251 B-upper_bound
years 50 55 1252 1257 I-upper_bound

SGOT 0 4 1258 1262 B-clinical_variable
( 5 6 1263 1264 I-clinical_variable
AST 6 9 1264 1267 I-clinical_variable
) 9 10 1267 1268 I-clinical_variable
< 11 12 1269 1270 O
1.5 13 16 1271 1274 B-upper_bound
x 17 18 1275 1276 I-upper_bound
upper 19 24 1277 1282 B-clinical_variable
limit 25 30 1283 1288 I-clinical_variable
of 31 33 1289 1291 I-clinical_variable
normal 34 40 1292 1298 I-clinical_variable
( 41 42 1299 1300 I-clinical_variable
ULN 42 45 1300 1303 I-clinical_variable
) 45 46 1303 1304 I-clinical_variable
for 47 50 1305 1308 O
age 51 54 1309 1312 B-age

SGPT 0 4 1313 1317 B-clinical_variable
( 5 6 1318 1319 I-clinical_variable
ALT 6 9 1319 1322 I-clinical_variable
) 9 10 1322 1323 I-clinical_variable
< 11 12 1324 1325 O
1.5 13 16 1326 1329 B-upper_bound
x 17 18 1330 1331 I-upper_bound
upper 19 24 1332 1337 I-upper_bound
limit 25 30 1338 1343 I-upper_bound
of 31 33 1344 1346 I-upper_bound
normal 34 40 1347 1353 I-upper_bound
( 41 42 1354 1355 I-upper_bound
ULN 42 45 1355 1358 I-upper_bound
) 45 46 1358 1359 I-upper_bound
for 47 50 1360 1363 O
age 51 54 1364 1367 B-age

Serum 0 5 1368 1373 B-clinical_variable
creatinine 6 16 1374 1384 I-clinical_variable
≤ 17 18 1385 1386 O
1.5 19 22 1387 1390 B-upper_bound
mg 23 25 1391 1393 I-upper_bound
/ 25 26 1393 1394 I-upper_bound
dl 26 28 1394 1396 I-upper_bound

Stage 0 5 1397 1402 B-lower_bound
IB2 6 9 1403 1406 I-lower_bound
- 9 10 1406 1407 O
IVA 10 13 1407 1410 B-upper_bound
cervical 14 22 1411 1419 B-cancer
cancer 23 29 1420 1426 I-cancer
or 30 32 1427 1429 O
stage 33 38 1430 1435 O
I 39 40 1436 1437 O
with 41 45 1438 1442 O
biopsy 46 52 1443 1449 B-treatment
- 52 53 1449 1450 O
proven 53 59 1450 1456 O
pelvic 60 66 1457 1463 B-cancer
node 67 71 1464 1468 I-cancer
metastases 72 82 1469 1479 I-cancer
, 82 83 1479 1480 O
positive 84 92 1481 1489 O
surgical 93 101 1490 1498 O
margins 102 109 1499 1506 O
, 109 110 1506 1507 O
or 111 113 1508 1510 O
parametrial 114 125 1511 1522 O
extension 126 135 1523 1532 O
based 136 141 1533 1538 O
upon 142 146 1539 1543 O
standard 147 155 1544 1552 O
diagnostic 156 166 1553 1563 O
workup 167 173 1564 1570 O

